PARTICIPANTS NEEDED FOR A SHINGRIX AND INFLUENZA VACCINE STUDY

This research study aims to compare the safety of administering Shingrix (shingles vaccine) at the same time as FLUAD® or Fluzone® High-Dose influenza vaccines in older people

START PRACTICING MEDITATION

Visit the Kadampa Meditation Center and learn to meditate in an authentic way that has been used for centuries to reduce mental and physical suffering and increase the power of the mind, resulting in greater peace and happiness. This class takes place on Sat., March 4, from 11 a.m. to 12:30 p.m. at 900 East Northern Pkwy., Baltimore. The first class is free; after that, the cost is $12 ($8 for seniors). For more information and to register, email epc@meditationmd.org.

Who is eligible?

If you are 65 years or older, have not yet received a Shingrix (shingles) vaccine and have not received this year’s flu shot, you may be eligible for the study

Time commitment

This study occurs over 3.5 months with 4 clinic visits and 5 phone calls

Benefits to participating

If you enroll you will receive the Shingrix and Influenza vaccines free of charge as well as earn up to $325

The PI for this study is Dr. Kawsar Talaat. All clinic visits will take place at the Center for Immunization Research sites at Johns Hopkins Bayview Campus, located at 301 Mason Lord Drive, Suite 4300, Baltimore, MD 21224, and/or at 1101 North Point Blvd Suite 101 103 112, Baltimore, MD, 21224

If you are interested in participating, please email JHSPH.projectSAVE@jhu.edu, call 410-955-7283 or scan the QR code